World’s most prescribed COPD treatment goes combo


lung radiography, pneumonia awareness
Boehringer Ingelheim has announced the availability of the first tiotropium-based combination therapy on the PBS for the treatment of chronic obstructive pulmonary disease (COPD). PBS listed from 1 December, Spiolto Respimat combines 5μg of tiotropium and 5μg of olodaterol in the Respimat Soft Mist inhaler. The therapy has been shown to offer improvements beyond tiotropium

This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous One national scheme to cultivate medicinal cannabis: Ley
Next Closing the Gap targets won't be met: Productivity Commission